Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

Recruiting N/A Interventional Study
Hyponatremia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
60 (estimated)
Sponsor
University of Cologne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Hyponatremia is the most common electrolyte disorder of all and can be observed in more than 30% of all patients in hospitals. Osmotic homeostasis of body fluids is essential for survival of all living creatures. It is widely accepted that extra- and intracellular osmolalities are in equilibrium at all times and thus, changes in the extracellular osmolality will lead to either shrinkage or swellin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients ≥18 years * Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason * Stable hemodialysis treatment for at least 3 months * Urine output \<100ml in 24 hours * Glucose-corrected plasma sodium be…
Contacts

Volker Burst, MD

+49 221 478 86285

volker.burst@uk-koeln.de

CONTACT

Sadrija Cukoski, MD

sadrija.cukoski@uk-koeln.de

CONTACT